August 28-30, 2017
Philadelphia, PA

Main Conference Day Two

9:00 am - 9:45 am KEYNOTE: Streamlining the Process: Maximize Usability and Minimize Costs from Compounds to Biologics

9:45 am - 10:30 am PANEL DISCUSSION: The Extension of Your Lab: Building Best-Practices for CRO Partnership

Elizabeth Admirand - Principle Research Associate, Lead Discovery, Epizyme

Elizabeth Admirand

Principle Research Associate, Lead Discovery

11:15 am - 12:00 pm CASE STUDY: The Evolution of Compounds Management at AstraZeneca Boston

Jeff Andrews - Senior Research Scientist, AstraZeneca

Jeff Andrews

Senior Research Scientist

12:00 pm - 12:45 pm Blending Compound, Biological, and Clinical Sample Storage

1:45 pm - 2:30 pm Integrating Automation and a High-Performance Team within a Compound Management Environment

Jefferson Chin - Analytical Chemist/Lab Manager, Bristol-Myers Squibb

Jefferson Chin

Analytical Chemist/Lab Manager
Bristol-Myers Squibb

2:30 pm - 3:15 pm Fostering Pre-Competitive Partnerships with Big Pharma and Biobanks to Further Sequencing Efforts

8:00 am - 12:00 am ROUNDTABLE DISCUSSIONS: Join the conversation with your peers on the hottest topics in the industry!


Leading Through Change and Organizational Restructuring
Discuss how to build a cohesive, agile team capable of performing during organizational shifts
Focus on the institutional knowledge, retention, ROI, and culture, of both contract staff and company staff


The Lab Of The Future
Employ principles of lean six sigma to assist in reducing non-value-added work from a process level—in lab design


Data Curation
How accurate is your data?  Have you performed an audit?  
Learn the true quality of your data—prior to upgrading your systems  

4:30 pm - 5:15 pm Alliance, Collaborations and Due Diligence for CRO Efforts: Successful Integration into the Discovery Pipeline

Robert Hutchins - Research Scientist I, Bristol-Myers Squibb

Robert Hutchins

Research Scientist I
Bristol-Myers Squibb